Evidence map›Paper›PMID 34539183›Full record

ArticleInternational journal of general medicine2021

A Pan-Cancer Analysis of the Prognostic Value and Expression of Adenylate Cyclase 7 (ADCY7) in Human Tumors.

Yu Zeng, Nanhong Li, Zhenzhen Zheng, Riken Chen, Wang Liu, Jinru Zhu, Mingqing Zeng, Junfen Cheng, Min Peng, Cheng Hong

Open access · goldAbstract read
In one paragraph

Article in International journal of general medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yu Zeng *Department of Respiration, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, People's Republic of China.ORCID 0000-0003-0970-9537
Nanhong Li *Department of Pathology and Pathophysiology, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Zhenzhen ZhengDepartment of Respiration, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, People's Republic of China.
Riken ChenChina State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
Wang LiuDepartment of Respiration, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, People's Republic of China.
Jinru ZhuDepartment of Respiration, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, People's Republic of China.
Mingqing ZengFirst Clinical School of Medicine, Guangdong Medical University, Zhanjiang, Guangdong, People's Republic of China.
Junfen ChengDepartment of Respiration, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, People's Republic of China.
Min PengDepartment of Respiration, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, People's Republic of China.
Cheng HongChina State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
Guangdong Medical College · CNFirst Affiliated Hospital of Guangzhou Medical University · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe role of adenylate cyclase 7 (ADCY7) in cancer is still unclear. This study analyzed the interrelationship between the expression and immune function of ADCY7.

methodsADCY7 expression in multiple human cancers was analyzed using the databases of Genotype-Tissue Expression Project (GTEx), Cancer Cell Line Encyclopedia (CCLE), and The Cancer Genome Atlas (TCGA). Correlations among ADCY7 gene expression, mismatch repair (MMR) gene expression, and DNA methyltransferase (DNMT) expression were assessed using Spearman correlation analysis. Univariate survival analysis and Kaplan-Meier (KM) curve were used to examine the effect of ADCY7 expression on prognosis. The Tumor Immune Estimation Resource (TIMER) database was used to evaluate the relationship between ADCY7 gene expression and tumor immune invasion or immune checkpoint gene (ICG) expression.

resultsADCY7 was abnormally expressed in multiple human cancers and was correlated with MMR genes and DNMT expression. Univariate survival analysis and KM curve showed that ADCY7 expression influences the overall survival (OS) of six types of cancer, disease-specific survival (DSS) of eight, and progression-free interval (PFI) of three. The high expression of ADCY7 in OS, DSS, and PFI was strongly associated with poor outcomes in patients with breast cancer and lung squamous cell carcinoma. ADCY7 expression was strongly associated with immune cell infiltration and ICG expression.

conclusionThe results of this study indicated that ADCY7 may be a prognostic biomarker of tumorigenesis. The study may also provide a new perspective on the role of ADCY7 in human cancers.

Indexed as

ADCY7adenylate cyclase 7biomarkerimmune infiltrationpan-cancer analysisprognosis

Identifiers

PMID34539183
PMCPMC8445103
OpenAlexW3199741808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.